Immunization with purified DNA is a powerful technique for inducing immune responses. The concept of DNA immunization involves insertion of the gene encoding the antigen of choice into a bacterial plasmid and injection of the plasmid into the host where the antigen is expressed and where it induces humoral and cellular immunity. The most effective routes and methods for DNA immunization are bombardment with particles coated with DNA (''gene gun'' technique), followed by the intramuscular and intradermal routes. DNA immunization technology has the potential to induce immunity to all antigens that can be completely encoded in DNA, which therefore include all protein, but not carbohydrate, antigens. DNA immunization results in presentation of antigens to the host's immune system in a natural form, like that achieved with live-attenuated vaccines. The DNA immunization strategy has the potential to rapidly provide a new vaccine in the face of an emerging influenza pandemic.
The Concept and the Construct Used for DNA Each February, the World Health Organization collaboratImmunization ing laboratories meet to review information obtained from ú110 laboratories worldwide and decide which strains best
The concept of DNA immunization is illustrated in figure 1 . represent those that are likely to be dominant in the next A DNA copy of the RNA segment of influenza virus encoding, year. Experience at reviewing the data and some good guessfor example, the hemagglutinin (HA) protein is inserted into a work have resulted in surprisingly good matches with the bacterial plasmid. The circular plasmid, which can replicate in influenza virus that has become dominant in recent years.
bacteria, contains control elements including a strong eukaryAfter the decision on vaccine strains is made, preparation otic promoter of cytomegalovirus (cytomegalovirus early proof high-growth reassortants and of the vaccine takes up to moter), intron A, and sequences encoding a tissue plasminogen 6 months, and since the viruses continue to evolve in nature, activator, which enables expression of the HA protein in the the vaccine strain used can be as much as 1 year out of date B cells of a mammalian host. Other characteristics that are by the time the vaccine is administered to humans. Theredesirable in expression vectors for DNA immunization include fore, although the development of a ''new'' vaccine each a high copy number and lack of replication or integration into year is truly remarkable, in terms of virus variability, the the host chromosome. The plasmid DNA for vaccination must time required is too long. This lag could pose serious probbe free of any contamination, particularly toxic or inherently lems when preparing for an influenza pandemic, especially antigenic substances such as endotoxins and antibiotics. The in the worst-case scenario of reappearance of a highly pathoaim is to express (in mammalian cells) high levels of a gene genic ''Spanish-type'' influenza. DNA immunization may product defining antigenic domains that will stimulate the deoffer certain advantages over conventional vaccination stratsired immune response. egies involving inactivated intact virus or subunit vaccines.
Administration of DNA Vaccines
The first report of protective immunity induced by DNA of This article is part of a series of papers presented at a symposium entitled an infectious agent (in this case, influenza) was published in ''International Conference on Acute Respiratory Infections'' that was held 7 - 1993 [1, 2] , and this technology was quickly applied to a wide 10 July 1997 in Canberra, Australia. This symposium was organized by the Cochrane Collaboration Review Group on Acute Respiratory Infections and range of disease agents, including viruses, bacteria, parasites, the National Centre for Epidemiology and Population Health at The Australian and cancer-associated pathogens [3] . The routes of inoculation National University. is the use of a gene-gun to shoot DNA-coated gold beads Reprints (2) Induction of cross-reactive (heterotypic) immunity to influenza viruses. Influenza viruses show continuous antigenic drift, which makes it necessary to change human vaccine strains almost every year to keep abreast of antigenic changes in the HA and neuraminidase (NA). The nucleoprotein (NP) of influenza virus, one of the antigenically conserved internal proteins, is important in the induction of cross-reactive cytotoxic T lymphocytes (CTLs) and recovery from infection, but it does not provide significant protection from initial infection.
The demonstration that DNA immunization with the NP of influenza A provides heterotypic immunity between different subtypes of influenza A in mice [2, 8] is important if this phenomenon is shown to extend to animals naturally infected with influenza, including humans, pigs, horses, and chickens. Studies on the preclinical efficacy of contemporary human vaccine strains in ferrets and nonhuman primates suggest that DNA expression vectors encoding HA and internal proteins were more efficient than were conventional inactivated or subvirion vaccines [9] . Preliminary studies with DNA vaccine to the NP of A/PR/8/34 (H1N1) in mice failed to provide protection from homologous challenge [10] , indicating some controversy about the claims of cross-protection between subtypes and a need for more studies to determine if heterotypic immunity to influenza induced by NP applies across all subtypes and in naturally infected hosts. is equivalent to live vaccination in protecting mice from challenge [11, 12] . Two doses of intradermal gene-gun-administered DNA vaccine provided 100% protection, as did a livevirus vaccine, whereas a subunit vaccine provided only 70% 34 (H1N1) provided 100% protection from challenge after one immunization.
protection. The antibody-producing cells localized in the spleen and bone marrow after vaccination; after challenge these cells were found in the lymph nodes draining the lungs. CD4 / cells DNA Immunization for Influenza were vital for induction of antibody-forming cells because treatment with anti-CD4 / antibody completely abolished antibodyInfluenza virus has served as a model system to understand the mechanism(s) by which DNA vaccines induce immunity.
forming cells from all compartments. The immunity induced by DNA immunization was maintained in the spleen and bone (1) Induction of protective immunity to influenza in chickens. The initial demonstration of induction of protective immunity marrow for at least 1 year [11] . Studies in ferrets and nonhuman primates [9] confirm that DNA immunization is more effective to influenza virus by DNA immunization was in chickens, with use of a plasmid containing the hemagglutinin of the H7 subthan use of conventional influenza virus subunit vaccines.
(4) Broadening of the antibody response to the HA of influtype [1] . Chickens were immunized by multiple routes (intravenous, intraperitoneal, subcutaneous) with large doses (300 mg enza virus. Preliminary evidence suggests that DNA immunization may more effectively induce cross-reactive antibody of DNA) and were boosted prior to challenge with 100L D50 of lethal A/chicken/Victoria/83(H7N7). The chickens were prothan vaccination with live influenza virus. Immunization of ferrets with DNA encoding the HA of A/PR/8/34 (H1N1) intected from challenge with a lethal avian influenza H7N7 virus (A/chicken/Victoria/83). DNA immunization of chickens failed duced antibodies that cross-reacted with A/swine/Shope/30 (H1N1) [13] . This cross-reaction was not found after natural to induce a detectable primary antibody response but primed / 9c61$$fe37 01-22-99 12:17:41 cida UC: CID infection of ferrets. These studies indicate the potential for rigorous testing of the immunogenicity of plasmid DNA, mice prone to autoimmunity (B/W) and control mice (Balb/c) were inducing high-affinity antibodies. In addition, these preliminary results warrant further study, for if cross-reactive antibodies immunized with a plasmid encoding the glycoprotein of Plasmodium yoelii [22] . The patterns of the immune responses in are induced, it may be possible to reduce the frequency at which influenza vaccine strains are changed. both strains were similar, and there was no evidence that the B/W mice produced antibodies to DNA that interfered with (5) Modulation of the antibody isotype by DNA immunization. There is increasing evidence that DNA immunization vaccine effectiveness. Therefore, the formation of antibodies to DNA and the induction of autoimmune disease are considpermits the investigator to modulate the immune response by targeting a T-helper (TH)-1 or TH-2 response [14] . Intramuscuered to be unlikely consequences of the administration of plasmid DNA. lar or intradermal DNA vaccination of mice with the HA of influenza virus induces primarily IgG2a antibodies, whereas (2) Altered immune state. Events that may lead to an altered immune state include the induction of tolerance, autoimgene-gun immunization produces mainly IgG1 antibodies. Therefore, different methods of delivering DNA vaccines can munity, anaphylaxis, hyperimmunity, and autoaggression. Studies in neonatal mice with a vector that expressed the rabies influence the isotype of the antibodies produced [15] . Intramuscular immunization may result in TH-1-like responses, due to virus glycoprotein induced B and T cell responses, with no evidence of induction of tolerance [23] . At the present time, the predominance of IgG2a antibodies, CTL activity, and IFN-g production and to the lack of IL-4 release. In contrast, all of these consequences remain theoretical considerations. Thus far, no evidence suggests that these possible scenarios gene-gun immunization appears to elicit a TH-2 response [16] .
(6) Manipulation of the immune response with cytokine are practical concerns [19] . (3) Transformation. Theoretically, the introduction of exgenes. In addition to altering the character of the immune response, the cytokines induced by the plasmids used for DNA traneous DNA could lead to the formation of tumor cells through the insertion into or deactivation of a suppressor gene immunization can alter the intensity of the response [14] . Cytokines play a central role in the immune response by promoting [24] . PCR analysis was used to look for sequences from an influenza NP-DNA vaccine plasmid and demonstrated that no the activation of specific and nonspecific effector mechanisms. Inoculation of mice with vectors that expressed granulocyteintegration could be detected [25] . Although direct inoculation of oncogene DNA can induce tumors, the risk of induction of macrophage colony-stimulating factor and the rabies glycoprotein enhanced the B and TH cell activity against rabies virus, tumors by plasmids specifically designed for DNA immunization is several orders of magnitude below that associated with whereas concurrent inoculation with an additional plasmid expressing IFN-g resulted in a decreased immune response [17] .
the spontaneous mutation rate of human DNA. Additional testing for integration is needed before DNA vaccines will be Coexpression of other cytokines, including IL-6 [18], has also been shown to augment the immune response to DNA generally accepted for use in humans. vaccines encoding the HA of influenza viruses. Therefore, inoculation of mixtures of plasmids that encode antigen or cytokines or of polycistronic vectors that express both may improve the Mechanisms of Induction of Immunity to DNA efficacy of DNA immunization. Most importantly, DNA immuImmunization nization has the potential for yielding further insight into the interplay of antigen and cytokine in the modulation of immune In part, live attenuated vaccines are so effective because they activate CD8
/ and CD4 / precursor cells that give rise to the responses.
Although this article concentrates on the immune response major antiviral effector cells: the major histocompatibility complex (MHC) class 1 -restricted CTLs and the class II -restricted induced by DNA immunization for influenza virus, the available evidence indicates that it is equally applicable to other TH cells [26] . The reason for this resides in the cell biology of the synthesis, assembly, and transport of the MHC class I respiratory pathogens, including respiratory syncytial virus, pneumococcus, and all protein-based antigens.
molecule. The effective specific immune response to viral and parasitic diseases that is induced by DNA immunization involves both cell-mediated and antibody-mediated immunity.
Safety Considerations
The available information supports the idea that like live-attenuated vaccines, DNA immunization results in presentation of The introduction of genetic information into mammalian hosts raises several safety considerations. These include (1) antigens in a natural form to the host immune system (figure 2). One model for the priming of humoral and cellular immune the formation of antibodies to DNA, (2) the unexpected and untoward consequences of persistent expression of a foreign responses by DNA vaccines reflects the distinct pathways of MHC class I and class II antigen processing in cell culture. antigen, and (3) the potential for causing transformation [19] .
(1) Antibodies to DNA. Studies to date indicate that there Immune responses are thought to occur when antigen that is encoded by the plasmid-containing myocyte or keratinocyte is is no evidence of antibody induction against the DNA of mice or humans, even after repeated injections [20, 21] up by macrophages and B cells, thereby initiating a TH-dependemic, and distributing and administering vaccines to an increasing world population will continue to be an enormous dent antibody response. logistic problem. Our as-yet limited knowledge of DNA vaccination technology already suggests that DNA vaccines may Potential Advantages of DNA Immunization and Future greatly alleviate these concerns. Understanding the mechaDirections nisms by which plasmid DNA is taken up and expressed and the means to manipulate the multiple parameters involved in The potential advantages of DNA immunization are that it B and T cell responses may lead us to discover strategies (1) may increase the rapidity with which new vaccines with for directing the immune response to conserved but currently genetic identity are generated; (2) induces long-lasting protecnonantigenic regions of the influenza HA and NA. Providing tive immunity; (3) mimics immunization with live-attenuated that DNA vaccines meet the safety requirements discussed vaccine while eliminating the possibility of contamination with above, this method of immunization will likely play an imundesirable adventitious agents from the culture system; (4) portant role in future strategies to control influenza and many provides correct MHC class I presentation of antigen; (5) other diseases. allows concurrent administration of multiple DNA-encoded antigens and/or cytokines; (6) provides genetic stability of the immunizing plasmid; (7) 
